These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37902585)
1. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. Meriç N; Albayrak E; Gülbaş Z; Kocabaş F Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585 [TBL] [Abstract][Full Text] [Related]
2. The Historical Relationship Between Meis1 and Leukemia. Meriç N; Kocabaş F Adv Exp Med Biol; 2022; 1387():127-144. PubMed ID: 35304708 [TBL] [Abstract][Full Text] [Related]
3. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Wang GG; Pasillas MP; Kamps MP Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484 [TBL] [Abstract][Full Text] [Related]
4. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707 [TBL] [Abstract][Full Text] [Related]
5. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Lawrence HJ; Rozenfeld S; Cruz C; Matsukuma K; Kwong A; Kömüves L; Buchberg AM; Largman C Leukemia; 1999 Dec; 13(12):1993-9. PubMed ID: 10602420 [TBL] [Abstract][Full Text] [Related]
6. MEIS1 and HOXA7 genes in human acute myeloid leukemia. Afonja O; Smith JE; Cheng DM; Goldenberg AS; Amorosi E; Shimamoto T; Nakamura S; Ohyashiki K; Ohyashiki J; Toyama K; Takeshita K Leuk Res; 2000 Oct; 24(10):849-55. PubMed ID: 10996203 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression. Juul-Dam KL; Shukla NN; Cooper TM; Cuglievan B; Heidenreich O; Kolb EA; Rasouli M; Hasle H; Zwaan CM Eur J Med Genet; 2023 Dec; 66(12):104869. PubMed ID: 38174649 [TBL] [Abstract][Full Text] [Related]
9. MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance. Rosales-Aviña JA; Torres-Flores J; Aguilar-Lemarroy A; Gurrola-Díaz C; Hernández-Flores G; Ortiz-Lazareno PC; Lerma-Díaz JM; de Celis R; González-Ramella Ó; Barrera-Chaires E; Bravo-Cuellar A; Jave-Suárez LF J Exp Clin Cancer Res; 2011 Dec; 30(1):112. PubMed ID: 22185299 [TBL] [Abstract][Full Text] [Related]
10. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice. Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578 [TBL] [Abstract][Full Text] [Related]
12. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Wang GG; Pasillas MP; Kamps MP Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900 [TBL] [Abstract][Full Text] [Related]
13. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896 [TBL] [Abstract][Full Text] [Related]
14. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922 [No Abstract] [Full Text] [Related]
15. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Shen WF; Rozenfeld S; Kwong A; Köm ves LG; Lawrence HJ; Largman C Mol Cell Biol; 1999 Apr; 19(4):3051-61. PubMed ID: 10082572 [TBL] [Abstract][Full Text] [Related]
16. Development of Small Molecule MEIS Inhibitors that modulate HSC activity. Turan RD; Albayrak E; Uslu M; Siyah P; Alyazici LY; Kalkan BM; Aslan GS; Yucel D; Aksoz M; Tuysuz EC; Meric N; Durdagi S; Gulbas Z; Kocabas F Sci Rep; 2020 May; 10(1):7994. PubMed ID: 32409701 [TBL] [Abstract][Full Text] [Related]
17. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia. Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911 [TBL] [Abstract][Full Text] [Related]
19. Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc. Garcia-Cuellar MP; Prinz A; Slany RK Haematologica; 2022 Nov; 107(11):2601-2616. PubMed ID: 35546301 [TBL] [Abstract][Full Text] [Related]
20. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia. Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]